Enhanced cross-recognition of SARS-CoV-2 Omicron variant by peptide vaccine-induced antibodies (vol 13, 1044025, 2023)

被引：0
|
作者：
Aparicio, Belen [1 ,2 ,3 ]
Ruiz, Marta [1 ,2 ,3 ]
Casares, Noelia [1 ,3 ]
Silva, Leyre [1 ,2 ,3 ]
Egea, Josune [1 ,2 ,3 ]
Perez, Patricia [4 ,5 ]
Albericio, Guillermo [4 ]
Esteban, Mariano [4 ]
Garcia-Arriaza, Juan [4 ,5 ]
Lasarte, Juan J. [1 ,3 ]
Sarobe, Pablo [1 ,2 ,3 ]
机构：
[1] Univ Navarra, CIMA, Pamplona, Spain
[2] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Pamplona, Spain
[3] Inst Invest Sanitarias Navarra IdiSNA, Pamplona, Spain
[4] CSIC, CNB, Madrid, Spain
[5] Ctr Invest Biomed Red Enfermedades Infecciosas CI, Madrid, Spain
来源：
FRONTIERS IN IMMUNOLOGY | 2023年 / 14卷
关键词：
SARS-CoV-2; peptide vaccine; Omicron variant; cross-recognizing antibodies; conserved regions;
D O I：
10.3389/fimmu.2023.1172427
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Enhanced cross-recognition of SARS-CoV-2 Omicron variant by peptide vaccine-induced antibodies
    Aparicio, Belen
    Ruiz, Marta
    Casares, Noelia
    Silva, Leyre
    Egea, Josune
    Perez, Patricia
    Albericio, Guillermo
    Esteban, Mariano
    Garcia-Arriaza, Juan
    Lasarte, Juan J.
    Sarobe, Pablo
    [J]. FRONTIERS IN IMMUNOLOGY, 2023, 13
  • [2] SARS-CoV-2 vaccine-induced antibodies protect against Omicron breakthrough infection
    Baerends, Eva A. M.
    Hvidt, Astrid K.
    Reekie, Joanne
    Sogaard, Ole S.
    Staerke, Nina B.
    Raben, Dorthe
    Nielsen, Henrik
    Petersen, Kristine T.
    Juhl, Maria R.
    Johansen, Isik S.
    Lindvig, Susan O.
    Madsen, Lone W.
    Wiese, Lothar
    Knudsen, Lene S.
    Iversen, Mette B.
    Benfield, Thomas
    Iversen, Kasper K.
    Andersen, Sidsel D.
    Juhl, Anna K.
    Dietz, Lisa L.
    Andreasen, Signe R.
    Fischer, Thea K.
    Erikstrup, Christian
    Valentiner-Branth, Palle
    Lundgren, Jens
    Ostergaard, Lars
    Tolstrup, Martin
    [J]. ISCIENCE, 2023, 26 (09)
  • [3] Waning natural and vaccine-induced immunity leading to reinfection with SARS-CoV-2 Omicron variant
    Shete, Anita M.
    Patil, Deepak Y.
    Sahay, Rima R.
    Sapkal, Gajanan N.
    Deshpande, Gururaj R.
    Yadav, Pragya D.
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (06)
  • [4] Vaccine-Induced SARS-CoV-2 Antibodies in Inflammatory Diseases
    Abbasi, Jennifer
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 326 (14): : 1365 - 1365
  • [5] Immune evasion of neutralizing antibodies by SARS-CoV-2 Omicron (vol 70 , pg 13 , 2023)
    Wang, Lidong
    Mohlenberg, Michelle
    Wang, Pengfei
    Zhou, Hao
    [J]. CYTOKINE & GROWTH FACTOR REVIEWS, 2024, 77 : 117 - 117
  • [6] Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence, Japan, 2023
    Kinoshita, Ryo
    Miyamoto, Sho
    Sakuraba, Shoko
    Sugihara, Jun
    Suzuki, Motoi
    Suzuki, Tadaki
    Yoneoka, Daisuke
    [J]. EMERGING INFECTIOUS DISEASES, 2024, 30 (06) : 1267 - 1270
  • [7] The SARS-CoV-2 Variant Omicron Is Able to Escape Vaccine-Induced Humoral Immune Responses, but Is Counteracted by Booster Vaccination
    Hastert, Florian D.
    Hein, Sascha
    von Rhein, Christine
    Benz, Nuka Ivalu
    Husria, Younes
    Oberle, Doris
    Maier, Thorsten J.
    Hildt, Eberhard
    Schnierle, Barbara S.
    [J]. VACCINES, 2022, 10 (05)
  • [8] COVID-19 vaccination induces humoral and cellular immunity to SARS-CoV-2 with cross-recognition of the Omicron variant and IgA secretion
    Ruhl, L.
    Kuehne, J. F.
    Beushausen, K.
    Keil, J.
    Christoph, S.
    Sauer, J.
    Falk, C. S.
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2022, 52 : 167 - 168
  • [9] Comparative Analysis of Vaccine-Induced Neutralizing Antibodies against the Alpha, Beta, Delta, and Omicron Variants of SARS-CoV-2
    Girl, Philipp
    von Buttlar, Heiner
    Mantel, Enrico
    Antwerpen, Markus H.
    Woelfel, Roman
    Mueller, Katharina
    [J]. VACCINES, 2024, 12 (05)
  • [10] SARS-CoV-2 vaccine-induced subacute thyroiditis
    Patel, Krupa R.
    Cunnane, Mary E.
    Deschler, Daniel G.
    [J]. AMERICAN JOURNAL OF OTOLARYNGOLOGY, 2021, 43 (01)
12345